AHCO compared with STLN: revenue, margins and what each company keeps, and the suppliers and customers both name

AHCOAdaptHealth Corp.

Mkt capRevenueRevenue

STLNStarling Oncology, Inc.

Mkt capRevenueRevenue

Compare

AHCOAdaptHealth Corp.

STLNStarling Oncology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AHCO

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±20.9%▲+6.26%×0.30

Q2 FY26±13.5%▼−38.04%×2.81

Q1 FY26±11.7%▼−9.89%×0.85

Feb 24 '26±12.4%▼−13.95%×1.12

STLN1 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±32.7%▼−45.97%×1.41

= impliedAHCO realized, solidSTLN realized, hatchedOne scale, both sides: full bar = 46%× = |realized| ÷ impliedSource: market data

AHCOAdaptHealth Corp.

7.34▼−0.94%· post 7.34

Mkt cap$1.0BRevenue$746MQ3 FY26Revenue$3.1BFY25

STLNStarling Oncology, Inc.

3.59▼−46.36%· post 3.62

ClosedNov 6 '26

Mkt cap$369.2MRevenue$170MQ3 FY26Revenue$503MFY25

Compare

ClosedNov 6 '26

AHCOAdaptHealth Corp.

STLNStarling Oncology, Inc.

7.34▼−0.94%post 7.34

Price

3.59▼−46.36%post 3.62

$1.0B

Mkt cap

$369.2M

Q3 FY26$746M

Revenue

$170MQ3 FY26

FY25$3.1B

Revenue

$503MFY25

AHCO7.34▼−0.94%vsSTLN3.59▼−46.36%ClosedNov 6 '26